Ferguson Merle
- SEC CIK
- 0001749860
In the past year, 1 open-market sale filing worth $400.5K and no purchases.
Current role at each company
- BFNH Bioforce Nanosciences Holdings, Inc.Directoras of Sep 2, 2026
- GRHI Gold Rock Holdings, Inc.Presidentas of Oct 4, 2023
- BRVO Bravo Multinational Inc.CEOas of Apr 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $400.5K
- 1 filing
- Net
- −$400.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ferguson Merle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BFNH Bioforce Nanosciences Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)4:09 PM ET | Apr 22 | 133 daysLate | Ferguson MerleDirector | SSaleCommon Stock; Par Value $0.001 | −26.7M | $0.015 | −$400.5K | −100.0%0 after |
GRHI Gold Rock Holdings, Inc.
President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 (view filing) | Oct 2 | 2 days | Ferguson MerlePresident | SSale | −199.7M | $0.00 | $0 | −100.0%2.95K after |
BRVO Bravo Multinational Inc.
CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 (view filing)4:37 PM ET | Apr 11 | 1 day | Ferguson MerleCEO | SSale | −30.0M | $0.02 | −$600.0K | −100.0%0 after |